openPR Logo
Press release

Porcine Vaccines Market Size & Share to See Modest Growth Through 2026 By Key Players Like Bayer AG, Bimeda Animal Health, Boehringer Ingelheim GmbH, Ceva Sante Animale, Eli Lilly and Company

06-06-2019 09:46 AM CET | Health & Medicine

Press release from: Coherent Market Insights - Biotechnology

Porcine Vaccines

Porcine Vaccines

Vaccines are the most imperative mediations for disease control among animals and humans. Under veterinary pharmaceuticals, vaccination is considered as a windfall for maintaining animal health by preventing spread of several endemic diseases. Such diseases which can be endemic are porcine reproductive and respiratory virus (PRRSV), swine influenza, diarrhea, porcine circovirus associated disease (PCVAD). Furthermore, cholera, high fever, foot and mouth diseases in swine have been significantly eliminated in North America through immunization.

Ask For Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1685

Porcine Vaccines Market – Driver

Increasing demand for gelatin is projected to support the growth of the market, as porcine gelatin is used as a stabilizer to ensure safety and efficacy of vaccine during storage. Furthermore, rising demand for meat, milk, eggs, & animal protein and concerns regarding the increasing incidences of zoonotic diseases are expected to propel the growth of the porcine vaccines market during the forecast period. For instance, Vietnam is the third country in the world by per-capita pig meat consumption, with an average of 29.14 kilos of meat consumed in 2015.

Moreover, increasing number of biotechnology companies, research institutes engaged in research and development of porcine vaccines, and government initiatives for funding agriculture and animal husbandry sector are some of the factors fueling growth of the global porcine vaccines market. For instance, in 2014, the International Livestock Research Institute (ILRI) initiated a program to raise pig farming more efficiently. These program highlighted three factors to support pig farming, which include improving feeding through public-private partnerships, improving the breeding and housing of village pigs, and controlling classical swine fever, a highly contagious and potentially fatal disease of pigs. Thus, all these initiatives are expected to augment growth of the market over the forecast period.

Porcine Vaccines Market – Competitive Landscape

Key players are introducing porcine vaccines with new features such as such as DNA vaccines, recombinant vaccines, and conjugate vaccines. This advanced vaccines are expected to improve the efficiency and effectively of swine production practices with reduction in overall vaccination cost.

Major players operating in porcine vaccines market include Bayer AG, Bimeda Animal Health, Boehringer Ingelheim GmbH, Ceva Sante Animale, Eli Lilly and Company, Merck & Co., Inc., Sanofi S.A, and Vetoquinol, Zoetis, Inc.

Discuss Your Queries With Our Analyst @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/1685

Porcine Vaccines Market - Regional Analysis

On the basis of geography, the global porcine vaccines market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the largest market share in the global porcine vaccines market, attributable to highly organized farming structure, increased demand for animal protein, and rising expenditure on animal health by farm owners. Moreover, export and import permits among contract manufacturers or distributer firms and low estimated cost of products are expected to make the porcine vaccine market more popular in Europe.

For instance, in 2016, a UK-based Cranswick Foods company initiated a project to set up pork processing plant in Punjab, which would act as a catalyst to hasten the process of value addition in animal husbandry sector and give boost to the farm diversification, providing high quality pork to the consumers across the state. The market in Asia Pacific (including Vietnam, the Philippines, etc.) is estimated to grow at a significant CAGR during the forecast period as this countries have large consumption of pig meat, which in turn is fostering growth of the market.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Porcine Vaccines Market Size & Share to See Modest Growth Through 2026 By Key Players Like Bayer AG, Bimeda Animal Health, Boehringer Ingelheim GmbH, Ceva Sante Animale, Eli Lilly and Company here

News-ID: 1766229 • Views: 369

More Releases from Coherent Market Insights - Biotechnology

Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …
Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. Free Request Sample Copy
Diabetes Vaccine Market Scrutinized in New Research 2018-2026
Diabetes is one of most prevalent chronic diseases worldwide. According to WHO (World Health Organization), diabetes was one of top three leading causes of mortality in 2012. The diabetes vaccine currently under development has significant potential in younger age group (Below 20 years age), who are characterized by a stronger autoimmune response to combat infection from specific viruses. Diabetes vaccine is being developed to strengthen the body’s response against enterovirus

All 5 Releases


More Releases for Vaccines

Global Influenza Vaccines Market
Global Influenza Vaccines Market Size, Share, Analysis, Growth, Trends, and Forecast to 2027 Worldwide Influenza Vaccines Market size is expected to exceed USD 7.5 billion by 2027. The report contains a deep analysis of the worldwide influenza vaccines market with size in terms of both value and volume. The report provides a clear insight into current and future developments of the worldwide influenza vaccines market. The report also explores a detailed analysis
Designing multi-purpose vaccines
Scientists from the five year EU funded project MycoSynVac report their findings and successes at a final meeting in Brussels. The project drew on cutting edge biotechnology to explore three important GOALS: 1. TRANSFORM a living bacteria (Mycoplasma pneumoniae) into a vaccine chassis 2. APPLY this vaccine chassis against bacterial diseases in livestock animals, 3. CONTRIBUTE to the reduction of antibiotics administered to farm animals A well-rounded approach to science featuring
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year
Global Veterinary Vaccines Market
The Global Veterinary Vaccines Market was valued at US$ 5,688.7 million in 2015 and is projected to expand at a CAGR of 5.9% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Rise in incidence of food-borne zoonotic diseases along with increase in population of livestock is expected to favor growth of the veterinary vaccines market. According to European food safety authority (EFSA),